Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5933
    -0.0001 (-0.02%)
     
  • NZD/EUR

    0.5545
    +0.0004 (+0.08%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.63
    -0.73 (-0.88%)
     
  • GOLD

    2,342.10
    0.00 (0.00%)
     
  • NASDAQ

    17,511.21
    +39.74 (+0.23%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,427.36
    -76.33 (-0.20%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • NZD/JPY

    91.9820
    +0.2160 (+0.24%)
     

Ozempic Could Boost Novo Nordisk’s Revenue Growth in 2018

In December 2017, the U.S. FDA (Food and Drug Administration) approved Novo Nordisk’s (NVO) Ozempic as an addition to diet and exercise for the improvement of blood sugar levels in individuals with type ...